Loading...
XJPX
7600
Market cap80mUSD
Dec 05, Last price  
473.00JPY
1D
-1.25%
1Q
-11.26%
Jan 2017
-42.81%
IPO
-85.22%
Name

Japan Medical Dynamic Marketing Inc

Chart & Performance

D1W1MN
XJPX:7600 chart
P/E
P/S
0.50
EPS
Div Yield, %
2.96%
Shrs. gr., 5y
-0.05%
Rev. gr., 5y
6.79%
Revenues
25.11b
+8.35%
11,447,224,00010,394,695,0009,894,445,0009,531,250,00008,134,461,0009,459,467,00011,855,226,00013,024,747,00013,629,522,00014,807,726,00016,728,891,00018,083,187,00016,738,174,00019,193,098,00021,307,946,00023,177,747,00025,114,033,000
Net income
-462m
L
286,749,000-226,702,000-2,358,375,00071,132,0000-397,894,000286,656,000-391,528,000800,546,0001,130,703,0001,425,466,0001,984,583,0002,164,945,0001,664,517,0002,135,693,0001,423,719,0001,271,683,000-461,799,000
CFO
1.05b
-50.28%
4,162,375,0002,882,433,0003,286,391,0001,742,797,0001,647,659,000-457,187,0001,967,953,0001,566,887,0002,038,193,0002,562,533,0002,367,421,0002,731,181,0002,599,761,0003,111,665,0002,186,226,0002,104,913,0001,046,627,000
Dividend
Mar 28, 20250 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury; spinal fixation devices for the use in spinal instability surgery; and artificial bone fillers for the treatment of bone fractures, tumors, and other defects. It offers its products to medical professionals and hospitals. The company was incorporated in 1973 and is headquartered in Tokyo, Japan.
IPO date
Mar 24, 2000
Employees
488
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT